Journal article · 2019 · Open access

Antiviral immunity is impaired in COPD patients with frequent exacerbations

Aran Singanayagam, Su-Ling Loo, Maria Adelaide Calderazzo, Lydia Finney, Maria‐Belen Trujillo‐Torralbo, Eteri Bakhsoliani, Jason L. N. Girkin, Punnam Chander Veerati, Prabuddha S. Pathinayake, Kristy Nichol, Andrew T. Reid, Joseph Footitt and 5 more

American Journal of Physiology-Lung Cellular and Molecular Physiology, 317(6), L893–L903 · Published 12 September 2019 · DOI 10.1152/ajplung.00253.2019

Open PDFView at the publisherCite this paper

In brief

“Antiviral immunity is impaired in COPD patients with frequent exacerbations” is a 2019 journal article by Aran Singanayagam and 16 co-authors, published in American Journal of Physiology-Lung Cellular and Molecular Physiology. OpenAlex counts 82 citations as of 21 November 2026, which puts it in the top 5% of works published in 2019 by citations. It is open access under a CC BY licence: the full text is free to read at American Journal of Physiology-Lung Cellular and Molecular Physiology.

Citations
82
Most cited in
2021 (16)
Field-weighted impact
7.06
References
51
Authors
17

Abstract

Patients with frequent exacerbations represent a chronic obstructive pulmonary disease (COPD) subgroup requiring better treatment options. The aim of this study was to determine the innate immune mechanisms that underlie susceptibility to frequent exacerbations in COPD. We measured sputum expression of immune mediators and bacterial loads in samples from patients with COPD at stable state and during virus-associated exacerbations. In vitro immune responses to rhinovirus infection in differentiated primary bronchial epithelial cells (BECs) sampled from patients with COPD were additionally evaluated. Patients were stratified as frequent exacerbators (≥2 exacerbations in the preceding year) or infrequent exacerbators (<2 exacerbations in the preceding year) with comparisons made between these groups. Frequent exacerbators had reduced sputum cell mRNA expression of the antiviral immune mediators type I and III interferons and reduced interferon-stimulated gene (ISG) expression when clinically stable and during virus-associated exacerbation. A role for epithelial cell-intrinsic innate immune dysregulation was identified: induction of interferons and ISGs during in vitro rhinovirus (RV) infection was also impaired in differentiated BECs from frequent exacerbators. Frequent exacerbators additionally had increased sputum bacterial loads at 2 wk following virus-associated exacerbation onset. These data implicate deficient airway innate immunity involving epithelial cells in the increased propensity to exacerbations observed in some patients with COPD. Therapeutic approaches to boost innate antimicrobial immunity in the lung could be a viable strategy for prevention and treatment of frequent exacerbations.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Singanayagam, A., Loo, S.-L., Calderazzo, M. A., Finney, L., Trujillo‐Torralbo, M., Bakhsoliani, E., Girkin, J. L. N., Veerati, P. C., Pathinayake, P. S., Nichol, K., Reid, A. T., Footitt, J., Wark, P. A. B., Grainge, C., Johnston, S. L., Bartlett, N. W., & Mallia, P. (2019). Antiviral immunity is impaired in COPD patients with frequent exacerbations. American Journal of Physiology-Lung Cellular and Molecular Physiology, 317(6), L893–L903. https://doi.org/10.1152/ajplung.00253.2019

MLA 9

Singanayagam, Aran, et al. “Antiviral immunity is impaired in COPD patients with frequent exacerbations.” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 317, no. 6, 2019, pp. L893–L903. https://doi.org/10.1152/ajplung.00253.2019.

Chicago

Singanayagam, Aran, Su-Ling Loo, Maria Adelaide Calderazzo, Lydia Finney, Maria‐Belen Trujillo‐Torralbo, Eteri Bakhsoliani, Jason L. N. Girkin, et al. 2019. “Antiviral immunity is impaired in COPD patients with frequent exacerbations.” American Journal of Physiology-Lung Cellular and Molecular Physiology 317 (6): L893–L903. https://doi.org/10.1152/ajplung.00253.2019.

Harvard

Singanayagam, A. et al. (2019) ‘Antiviral immunity is impaired in COPD patients with frequent exacerbations’, American Journal of Physiology-Lung Cellular and Molecular Physiology, 317(6), pp. L893–L903. doi:10.1152/ajplung.00253.2019.

IEEE

A. Singanayagam et al., “Antiviral immunity is impaired in COPD patients with frequent exacerbations,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 317, no. 6, pp. L893–L903, 2019, doi: 10.1152/ajplung.00253.2019.

BibTeX

@article{singanayagam2019antiviral,
  title     = {{Antiviral immunity is impaired in COPD patients with frequent exacerbations}},
  author    = {Singanayagam, Aran and Loo, Su-Ling and Calderazzo, Maria Adelaide and Finney, Lydia and Trujillo‐Torralbo, Maria‐Belen and Bakhsoliani, Eteri and Girkin, Jason L. N. and Veerati, Punnam Chander and Pathinayake, Prabuddha S. and Nichol, Kristy and Reid, Andrew T. and Footitt, Joseph and Wark, Peter A. B. and Grainge, Christopher and Johnston, Sebastian Lennox and Bartlett, Nathan W. and Mallia, Patrick},
  journal   = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year      = {2019},
  volume    = {317},
  number    = {6},
  pages     = {L893--L903},
  doi       = {10.1152/ajplung.00253.2019},
  url       = {https://doi.org/10.1152/ajplung.00253.2019}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201933
20201313
20211616
20221212
202366
20241414
202566
20261212

Its field-weighted citation impact is 7.06: it has been cited 7.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research

  • chronic obstructive pulmonary disease
  • COPD exacerbations
  • antiviral immunity
  • innate immunity
  • type I interferon
  • interferon lambda
  • interferon-stimulated genes
  • rhinovirus infection

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Singanayagam, A., Loo, S.-L., Calderazzo, M. A., Finney, L., Trujillo‐Torralbo, M., Bakhsoliani, E., Girkin, J. L. N., Veerati, P. C., Pathinayake, P. S., Nichol, K., Reid, A. T., Footitt, J., Wark, P. A. B., Grainge, C., Johnston, S. L., Bartlett, N. W., & Mallia, P. (2019). Antiviral immunity is impaired in COPD patients with frequent exacerbations. American Journal of Physiology-Lung Cellular and Molecular Physiology, 317(6), L893–L903. https://doi.org/10.1152/ajplung.00253.2019

How many times has this paper been cited?

82 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at American Journal of Physiology-Lung Cellular and Molecular Physiology: sign in and open the PDF from this page.

Who wrote this paper?

Aran Singanayagam, Su-Ling Loo, Maria Adelaide Calderazzo, Lydia Finney, Maria‐Belen Trujillo‐Torralbo, Eteri Bakhsoliani, Jason L. N. Girkin, Punnam Chander Veerati, Prabuddha S. Pathinayake, Kristy Nichol, Andrew T. Reid, Joseph Footitt and 5 more.

What is the DOI of this paper?

10.1152/ajplung.00253.2019, permanently at https://doi.org/10.1152/ajplung.00253.2019. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.